Vital Access™

About Vital Access

End-Stage Renal Disease

Products

Contact Us

Vital Access™ is committed to improving patient care through the
development of advanced surgical and interventional technologies that create and maintain vascular access.

High performance vascular access is critically important for
treatment success of patients undergoing hemodialysis with end-
stage renal disease.

Our products are currently under development and are not FDA-
approved. For more information or to learn about investment
opportunities, please contact us.

CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

Vital Access is conducting a clinical investigation of the Venous Window Needle Guide in the United States of America.

www.clinicaltrials.gov

(This Website is Currently Under Construction.)